Skip to main content

Type 2 Diabetes And Dementia

In Order to Read Online or Download Type 2 Diabetes And Dementia Full eBooks in PDF, EPUB, Tuebl and Mobi you need to create a Free account. Get any books you like and read everywhere you want. Fast Download Speed ~ Commercial & Ad Free. We cannot guarantee that every book is in the library!

The Interaction of Type 2 Diabetes Type 3 Diabetes Alzheimer s Disease and Thegut Microbiota

The Interaction of Type 2 Diabetes  Type 3 Diabetes  Alzheimer s Disease   and Thegut Microbiota Book
Author : Hyder Mirghani
Publisher : Grin Publishing
Release : 2018-01-12
ISBN : 9783668596795
Language : En, Es, Fr & De

GET BOOK

Book Description :

Literature Review from the year 2017 in the subject Medicine - Internal Medicine, grade: C, language: English, abstract: Dementia is a multifaceted syndrome with a significant public health, social, and economic burden; there are forty-four million people affected by the disease worldwide according to the most recent estimate.The number is projected to double by the year 2030 and to triple by 2050. Alzheimer's disease (AD, or type-3 diabetes mellitus) and vascular dementia are the most common forms of dementia. Lifestyle risk factors including obesity and type 2 diabetes increase the risk for the development of both vascular and nonvascular dementia in later life. Previous literature reported that people with diabetes mellitus had 70% greater risk for dementia development.Traditionally, type-2 diabetes and AD (type-3 diabetes) have been thought as independent disorders; recent literature suggests possible links that could lead to common effective modalities of treatment. Furthermore, the highly innervated pancreas shares many features with the brain at molecular levels. Metformin is recommended as the first line for the treatment of patients with type 2 diabetes mellitus due to its effectiveness, favorable effects on lipids and cardiovascular risks, and safety profile.The previous restriction of the use of metformin in patients with the moderate renal disease is loosened by the Food and Drug Organization(5,6). Thus the use of this valuable and affordable drug is expected to increase. The American Diabetes Association recommended the periodic measurement of vitamin B12 and supplementation as needed to reflect the recent evidence showing the association of long-term use of metformin and B12 deficiency.Although the role of vitamin B12 deficiency in the development of dementia is well-established, the role of metformin in B12 deficiency and dementia remain to be elucidated. Insulin resistance is considered as a primary factor for the association of diabetes melli

The interaction of type 2 diabetes type 3 diabetes Alzheimer s disease and the gut microbiota

The interaction of type 2 diabetes  type 3 diabetes  Alzheimer s disease   and the gut microbiota Book
Author : Hyder Mirghani
Publisher : GRIN Verlag
Release : 2017-12-19
ISBN : 3668596786
Language : En, Es, Fr & De

GET BOOK

Book Description :

Literature Review from the year 2017 in the subject Medicine - Internal Medicine, grade: C, , language: English, abstract: Dementia is a multifaceted syndrome with a significant public health, social, and economic burden; there are forty-four million people affected by the disease worldwide according to the most recent estimate.The number is projected to double by the year 2030 and to triple by 2050. Alzheimer's disease (AD, or type-3 diabetes mellitus) and vascular dementia are the most common forms of dementia. Lifestyle risk factors including obesity and type 2 diabetes increase the risk for the development of both vascular and nonvascular dementia in later life. Previous literature reported that people with diabetes mellitus had 70% greater risk for dementia development.Traditionally, type-2 diabetes and AD (type-3 diabetes) have been thought as independent disorders; recent literature suggests possible links that could lead to common effective modalities of treatment. Furthermore, the highly innervated pancreas shares many features with the brain at molecular levels. Metformin is recommended as the first line for the treatment of patients with type 2 diabetes mellitus due to its effectiveness, favorable effects on lipids and cardiovascular risks, and safety profile.The previous restriction of the use of metformin in patients with the moderate renal disease is loosened by the Food and Drug Organization(5,6). Thus the use of this valuable and affordable drug is expected to increase. The American Diabetes Association recommended the periodic measurement of vitamin B12 and supplementation as needed to reflect the recent evidence showing the association of long-term use of metformin and B12 deficiency.Although the role of vitamin B12 deficiency in the development of dementia is well-established, the role of metformin in B12 deficiency and dementia remain to be elucidated. Insulin resistance is considered as a primary factor for the association of diabetes mellitus and dementia. However, the role of insulin sensitizer in the prevention of dementia remains unclear.Furthermore, there is an increasing concern about the role of metformin in cognitive disorders.Thus we conducted this narrative review, in this study we reviewed the literature to assess the interaction of Alzheimer's disease, the gut, and its microbiome, and to assess the role of metformin and other drugs used for type 1&2 diabetes mellitus as possible therapies for the AD. The role of microbiota and fecal transplantation on cognitive disorders was also discussed.

Type 2 Diabetes and Dementia

Type 2 Diabetes and Dementia Book
Author : Velandai Srikanth,Zoe Arvanitakis
Publisher : Academic Press
Release : 2018-02-09
ISBN : 0128096942
Language : En, Es, Fr & De

GET BOOK

Book Description :

Type 2 Diabetes and Dementia details the relationship between diabetes, dementia and the future of medicine and therapeutics. Chapters range from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment and prevention strategies, and the application of therapeutics. The book reflects the translational aspects of the current science in the field, with an emphasis on the display of neuroimaging and neuropathology. It contains contributions from world experts, and is ideal for clinicians and researchers in the fields of neurology, neuroscience, geriatric medicine and endocrinology. Presents a comprehensive overview that details the relationship between diabetes, dementia and the future of medicine and therapeutics Written for researchers and clinicians in neurology, neuroscience, geriatric medicine and endocrinology Includes topics ranging from epidemiology, clinical features, neuroimaging biomarkers, neuropathology, macrostructural and molecular mechanisms, risk assessment, prevention strategies and therapeutic applications

Diabetes and the Brain

Diabetes and the Brain Book
Author : Geert Jan Biessels,Jose A. Luchsinger
Publisher : Springer Science & Business Media
Release : 2009-09-18
ISBN : 9781603278508
Language : En, Es, Fr & De

GET BOOK

Book Description :

Diabetes, particularly type 2, has become increasingly more common around the world. Consequently, the effect of diabetes on the brain has achieved enormous public health importance. A surge in pre-clinical and clinical research on topics ranging from management of hyperglycemia in acute stroke to disturbances in insulin signaling in Alzheimer’s disease has led to substantial progress in the field. Written by a panel of international experts, Diabetes and the Brain provides in depth reviews on the cerebral complications of diabetes, and offers introductory chapters on current insights on the pathophysiology and clinical management of diabetes, as well as neuropsychological assessment and dementia. This relevant and easily accessible book explains the cerebral complications of diabetes, with an update on diabetes for neurologists, psychiatrists, and mental health providers and researchers in general,and on stroke and dementia for those involved in research and clinical practice in diabetes.

A Study of Mechanisms Linking Type 2 Diabetes Mellitus and Dementia

A Study of Mechanisms Linking Type 2 Diabetes Mellitus and Dementia Book
Author : Christopher Moran
Publisher : Unknown
Release : 2015
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Background: Dementia is highly prevalent in older age, accounts for a significant proportion of age-related disability, and is one of the most expensive disorders affecting older Australians. T2DM affects about 85% of all people with diabetes and occurs more commonly in older age. T2DM increases the risk of vascular dementia and Alzheimer's dementia (AD) although there may be substantial overlap of the two pathologies. The underlying pathways between T2DM and dementia may involve neurodegeneration, vascular disease, or both, with several common intermediary mechanisms. Aims & methods: The broad aim of this thesis was to study the disease pathways that underlie the association between T2DM and dementia. The majority of the research presented was conducted within the Cognition and Type 2 Diabetes in Older Tasmanians (CDOT) study. A further study was conducted in a second sample, derived from the United States' Alzheimer's disease Neuroimaging Initiative (ADNI).Results: The main novel results of my thesis are summarised below:1.Brain atrophy is a key mediator of T2DM-related cognitive impairment and the regional distribution of brain atrophy seen in T2DM appears similar to that seen in early AD. 2.Tissue advanced glycation is associated with brain atrophy in T2DM (and in those without T2DM) and may partially mediate the association between T2DM and brain atrophy.3.T2DM is associated with excess production of CSF phosphorylated tau, and this partially mediates the association between T2DM and reduced cortical thickness, providing the first in-vivo evidence mechanistically linking T2DM with neurodegenerative AD-type pathology.4.Retinal vascular architecture and retinopathy (subclinical markers of small cerebral vessel disease) were not associated with MRI biomarkers of T2DM-related brain disease, raising speculation about the relative importance of vascular pathways leading to brain disease in people with T2DM receiving good glycaemic and vascular risk control. Conclusions: Brain atrophy is a key mediator of diabetes-related cognitive impairment and mechanisms similar to that seen in AD may play a role in T2DM-related cognitive impairment. These findings do not exclude the possibility that cerebrovascular disease or other non-AD-type processes contribute to T2DM-related cognitive impairment. A greater understanding of the mechanisms linking T2DM and dementia may facilitate development of new avenues for treatment of dementia.

The New Threat of Type 3 Diabetes

The New Threat of Type 3 Diabetes Book
Author : Alan D. Raguso,Maria Lizotte RN BSN CDE
Publisher : iUniverse
Release : 2018-11-08
ISBN : 1532053282
Language : En, Es, Fr & De

GET BOOK

Book Description :

The American diet is typically high in sugar consumption and extremely acidic. This lifestyle leads to insulin resistance, inflammation, diabetes, high blood pressure, risk for heart attack or stroke, and possibly dementia and Alzheimer’s disease. In The New Threat of Type 3 Diabetes, authors Alan D. Raguso and Maria Lizotte offer an understanding of diabetes, discussing why people’s health declines and why they get sick. Based on their personal and professional experiences with diabetes, they discuss concepts of body chemistry, look at inflammation as a health risk, and share how it’s a result of improper food intake, heredity, and environmental conditions, along with economics, poor pH balance, lack of moderate exercise, and the modern technological world. Raguso and Lizotte tell how type 3 diabetes is a newly accepted category, connecting a lifetime of damage caused by excessive blood sugar levels. With illustrations and graphics included, The New Threat of Type 3 Diabetes reviews the basic definitions of medical terms, the possible connections to prediabetes, type 2 and type 3 diabetes, and the steps that can be taken to prevent or reverse these diseases. Raguso and Lizotte suggest ways to make simple changes to live more healthily, better, and longer.

Diabetes Mellitus

Diabetes Mellitus Book
Author : Yusaku Nakabeppu,Toshiharu Ninomiya
Publisher : Springer
Release : 2019-05-06
ISBN : 9811335400
Language : En, Es, Fr & De

GET BOOK

Book Description :

This book describes the precise mechanisms by which insulin resistance and diabetes mellitus (DM) act as risk factors for Alzheimer’s disease (AD). It opens by discussing the de novo synthesis of insulin in the brain and its functional significance with regard to glucose metabolism and maintenance of neuronal function in the brain. The epidemiological evidence that DM is a risk factor for the development of dementia, including AD as well as vascular dementia, is then examined. Subsequent chapters explore in depth the mechanisms involved in this relationship, including abnormal protein processing, dysregulated glucose metabolism, impaired insulin signaling, and mitochondrial dysfunction. The molecular interactions between diabetes and AD are fully discussed, highlighting the pathological molecular mechanisms induced by diabetes that promote and accelerate AD pathology. Finally, diagnostic biomarkers and potential therapeutic approaches for AD are considered on the basis of the presented evidence. In providing answers to the critical questions of whether and why DM is a risk factor for AD, this book will hold appeal for a wide interdisciplinary audience.

The Diabetic Brain in Alzheimer s Disease How Insulin Resistance in Type 2 Diabetes and Type 3 Diabetes Triggers Your Risk for Alzheimer s and How

The Diabetic Brain in Alzheimer s Disease  How Insulin Resistance in Type 2 Diabetes and  Type 3 Diabetes  Triggers Your Risk for Alzheimer s and How Book
Author : Ralph Sanchez Mtcm
Publisher : Braindefend LLC
Release : 2019-08-21
ISBN : 9781732668706
Language : En, Es, Fr & De

GET BOOK

Book Description :

The thought of living out one's life with dementia conjures up a helpless and foreboding feeling. What if it happens to me?Can I do anything to prevent it?One in ten people age 65 and older has Alzheimer's, and the prevalence of the disease jumps to three in ten after the age of 85. One in three seniors will die from Alzheimer's or another form of dementia according to the Alzheimer's Association. The financial burden for top level care can be staggering, and the difficult challenges imposed by attending to care and finances can be extremely stressful and exhausting for family as well as caretakers.Is there an answer for you and the Alzheimer's pandemic that is projected to almost triple by the year 2050? To date, drug trials are struggling to provide any meaningful interventions, and it is unlikely that a pharmaceutical centered approach will provide anything resembling a cure or a reversal of the disease process anytime soon. There is hope! The solution is based on early detection and intervention. Scientific research as well as many enlightened physicians and clinics are now demonstrating that prevention is possible, and the key lies in a comprehensive evaluation of your risk for Alzheimer's long before the onset of dementia. This is vital as we now know that the Alzheimer's disease process starts decades before you might notice you are in trouble.Don't wait to be diagnosed! The Diabetic Brain in Alzheimer's Disease reveals the most critical and common risk factors for Alzheimer's disease as you age, and how you can take control of your risk. The in-depth science-based information in this book will illuminate your path to protecting your brain and drastically reducing your odds of developing Alzheimer's as you age. Read this book and discover the actionable steps that you can begin taking now to save your brain from dementia.

Diabetes and Aging An Issue of Clinics in Geriatric Medicine

Diabetes and Aging  An Issue of Clinics in Geriatric Medicine  Book
Author : Elsa S. Strotmeyer
Publisher : Elsevier Health Sciences
Release : 2014-12-26
ISBN : 0323354572
Language : En, Es, Fr & De

GET BOOK

Book Description :

This issue of Clinics in Geriatric Medicine, guest edited by Dr. Elsa S. Strotmeyer, is devoted to Medical Complications of Diabetes in Older Adults. Articles in this issue include: Glucose Dysregulation: Pathophysiology and Prevention; Diabetic Medications and Polypharmacy; Physical Function and Disability; Diabetes and Osteoarthritis; Adiposity, Muscle Mass, and Diabetes; Exercise and Weight Loss in Diabetes Management; Diabetes and Cognition; Diabetes and Depression; Sleep Apnea and Diabetes; Diabetes and Coronary Artery Disease; and Diabetes and Balance and Falls.

Diabetes in Old Age

Diabetes in Old Age Book
Author : Alan J. Sinclair,Trisha Dunning,Leocadio Rodríguez Mañas,Medha Munshi
Publisher : John Wiley & Sons
Release : 2017-02-13
ISBN : 1118954602
Language : En, Es, Fr & De

GET BOOK

Book Description :

This new edition of the popular and market-leading Diabetes in Old Age features up-to-date and comprehensive information about the key aspects of managing older people with diabetes, predominantly type 2 diabetes. With a strong evidence-based focus throughout, the entire range of issues surrounding diabetes and its many complications are covered, each with a clear focus on how they relate directly to the older patient. Varying approaches to optimizing diabetes care in the community, primary care and secondary care health care arenas are presented, and the importance of comprehensive functional assessment is emphasized. Coverage of areas unique to an ageing population of older people with diabetes such as falls management, frailty and sarcopenia, and cognitive dysfunction form a key cornerstone of the book. In every chapter, best practice points and key learning outcomes are provided, as well as published evidence bases for each major conclusion. Diabetes in Old Age, 4th edition is essential reading for diabetologists and endocrinologists, diabetes specialist nurses, primary care physicians, general physicians and geriatricians, podiatrists and dieticians with an interest in diabetes, as well as all health professionals engaged in the delivery of diabetes care to older people.

Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Risk of Dementia in Patients with Type 2 Diabetes and Hypertension

Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Risk of Dementia in Patients with Type 2 Diabetes and Hypertension Book
Author : Hemalkumar B. Mehta
Publisher : Unknown
Release : 2014
ISBN : 0987650XXX
Language : En, Es, Fr & De

GET BOOK

Book Description :

Objectives: Specific aims of the study were: (1) To develop RxDx risk index to predict dementia in patients with type 2 diabetes mellitus and hypertension (2) To compare RxDx risk index with different versions of Charlson comorbidity score (CCS) and chronic disease score (CDS) to predict dementia and (3) To compare Angiotensin Converting Enzyme (ACE) inhibitors versus Angiotensin Receptor Blockers (ARB) for the risk of dementia in patients with type 2 diabetes mellitus and hypertension. Methods: The Clinical Practice Research database was used for this retrospective longitudinal cohort study. Elderly patients (age>=65 years) diagnosed with type 2 diabetes and hypertension without prior diagnosis for dementia were included in the cohort. The Cox proportional hazard model was constructed to model time to dementia by incorporating age, gender and 31 RxDx disease conditions. Points were assigned to risk factors based on beta coefficients to obtain summary risk score. Different rick indices were compared against RxDx-Dementia risk index using c statistics, net reclassification improvement (NRI) and integrated discrimination improvement (IDI). A marginal structural model was constructed while controlling for demographic and clinical baseline variables and time-varying blood pressure variable to estimate causal effect of ACE inhibitors compared to ARB on the risk of dementia. Results: The incidence of dementia was 3.42% in patients with type 2 diabetes mellitus and hypertension. The c-statistics value for RxDx-Dementia risk index was 0.795 (95% confidence interval [CI], 0.789-0.801) and 0.806 (95% CI, 0.798-0.814). Based on the c-statisctics, NRI and IDI values the RxDx-Dementia risk index performed better compared to summary CCS, CDS scores and its combinations. The marginal structural model estimated statistically significant 39% (OR, 0.61; 95%CI, 0.50-0.77) reduction in the risk of developing dementia compared to ACE inhibitors. Conclusions: RxDx-Dementia risk index can be a useful tool to identify hypertensive diabetic patients who are at high risk of developing dementia as well as to control confounding in observational studies. ARB may offer protective effect on the risk of dementia compared to ACE inhibitors in patients with type 2 diabetes and hypertension. When there is no treatment available for dementia, prevention or delaying onset of dementia may help reduce the overall disease burden.

Life at Home for People with a Dementia

Life at Home for People with a Dementia Book
Author : Ruth Bartlett,Tula Brannelly
Publisher : Routledge
Release : 2018-06-14
ISBN : 1351619691
Language : En, Es, Fr & De

GET BOOK

Book Description :

Life at Home for People with a Dementia provides an evidence-based and readable account of improving life at home for people with a dementia and their families. There are estimated to be 47 million people with a dementia worldwide, the majority of whom will live, or want to live, in their own home. Yet there is a major shortcoming in available knowledge on what life is like for people with a dementia living at home. Most research focuses on care in hospitals or care homes, and takes a medical perspective. This book bridges this gap in knowledge by providing a comprehensive and critical overview of the best available evidence on enabling people with a dementia to live well at home from the viewpoint of those living with the condition, and in the context of global policy drivers on ageing and health, as well as technological advances. The book includes chapters on citizenships – that is, the diversity of people living with a dementia – enabling life at home, rethinking self-management, the ethics and care of people with a dementia at home, technological care and citizenship, and sharing responsibilities. It concludes with a care manifesto in which we set out a vision for improving life at home for people with a dementia that covers the areas of professional practice, education and care research. By covering a wide range of interrelated topics to advance understanding and practice as to how people with a dementia from diverse backgrounds can be supported to live well at home, this book provides a synthesised, critical and readable understanding of the complexities and risks involved.

The New Threat of Type 3 Diabetes

The New Threat of Type 3 Diabetes Book
Author : Alan D. Raguso,Maria Lizotte Rn Bsn Cde
Publisher : Unknown
Release : 2018-11-08
ISBN : 9781532053290
Language : En, Es, Fr & De

GET BOOK

Book Description :

The American diet is typically high in sugar consumption and extremely acidic. This lifestyle leads to insulin resistance, inflammation, diabetes, high blood pressure, risk for heart attack or stroke, and possibly dementia and Alzheimer's disease. In The New Threat of Type 3 Diabetes, authors Alan D. Raguso and Maria Lizotte offer an understanding of diabetes, discussing why people's health declines and why they get sick. Based on their personal and professional experiences with diabetes, they discuss concepts of body chemistry, look at inflammation as a health risk, and share how it's a result of improper food intake, heredity, and environmental conditions, along with economics, poor pH balance, lack of moderate exercise, and the modern technological world. Raguso and Lizotte tell how type 3 diabetes is a newly accepted category, connecting a lifetime of damage caused by excessive blood sugar levels. With illustrations and graphics included, The New Threat of Type 3 Diabetes reviews the basic definitions of medical terms, the possible connections to prediabetes, type 2 and type 3 diabetes, and the steps that can be taken to prevent or reverse these diseases. Raguso and Lizotte suggest ways to make simple changes to live more healthily, better, and longer.

Depression and Type 2 Diabetes

Depression and Type 2 Diabetes Book
Author : Khalida Ismail,Andreas Barthel,Stefan R. Bornstein,Julio Licinio
Publisher : Oxford University Press
Release : 2018-08-23
ISBN : 0192506285
Language : En, Es, Fr & De

GET BOOK

Book Description :

Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally. Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes. Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.

Increase your Brainability and Reduce your Risk of Dementia

Increase your Brainability   and Reduce your Risk of Dementia Book
Author : Charles Alessi,Larry W. Chambers,Muir Gray
Publisher : Oxford University Press
Release : 2021-05-27
ISBN : 0192604171
Language : En, Es, Fr & De

GET BOOK

Book Description :

Dreaded by many people as an inevitable part of normal aging, Dementia has displaced Cancer as the most feared health problem. Cancer continues to be a serious condition, but it is often curable, and almost always treatable. In contrast, the fear of dementia is complicated by the fear of ageing, and by muddled thinking about its relationship with Alzheimer's disease. Yet, there is no reason to be disheartened. Ever-evolving scientific evidence means that we can be increasingly optimistic about the future, and on-going research shows that the problems we dread- dementia, disability and dependency- can be controlled. By taking steps to limit damage to the brain caused by stress, sleep problems, and inactivity throughout our lives, it is more than possible to substantially reduce your risk of dementia. Equally, a loss of physical fitness (which starts long before old age) is preventable. Based on research from the Optimal Ageing Programme, and full of practical, evidence-based advice on managing the major risk factors underpinning dementia, this book will inspire readers to fight back against the modern environment and negative societal attitudes. Through simple but effective lifestyle changes that anyone can make, everyone can take positive action to increase their brainability. It is never too late to change your life, reduce your risk, and live better for longer.

Nutraceuticals Glycemic Health and Type 2 Diabetes

Nutraceuticals  Glycemic Health and Type 2 Diabetes Book
Author : Vijai K. Pasupuleti,James W. Anderson
Publisher : John Wiley & Sons
Release : 2009-03-03
ISBN : 0813804280
Language : En, Es, Fr & De

GET BOOK

Book Description :

Type 2 diabetes is a growing problem for the developed and developing countries and it is a burden on healthcare systems as well as individuals. Nutraceuticals, Glycemic Health and Type 2 Diabetes primarily focuses on the nutraceuticals that assist in preventing and managing prediabetes and type 2 diabetes. The book gives an overview of glycemic health and highlights the use of novel and upcoming nutraceutical ingredients such as bioactive peptides, traditional herbs from China, India and Mexico, resistant starches, cinnamon, chromium and others. After the successful commercial application of bioactive peptides as nutraceutical ingredients in the management of blood pressure, companies are now focusing on peptides for the prevention and management of type 2 diabetes. Resistant starches in the clinical studies have demonstrated to reduce the glycemic and insulin response and increasing insulin sensitivity. These and other nutraceuticals that are supported by scientific and clinical studies are highlighted. The editors and contributors are experts in their respective fields and are largely from the university, industry and government. Nutraceuticals, Glycemic Health and Type 2 Diabetes will be useful as a standard reference book for all those concerned with the role of nutraceuticals and glycemia in the prevention and control of type 2 diabetes.

Risk of Disability in Elderly Diabetic Patients

Risk of Disability in Elderly Diabetic Patients Book
Author : Claudio Marengo,Marco Comoglio
Publisher : SEEd
Release : 2011-09-30
ISBN : 8897419062
Language : En, Es, Fr & De

GET BOOK

Book Description :

In elderly population, diabetes is often associated with a wide range of complications and comorbidities that can affect the patients’ ability to care for themselves, thus complicating the medical assistance. Furthermore, old patients frequently have to follow polypharmacy regimens, that can increase adverse events and drug-drug interactions and reduce the compliance to hypoglycemic agents. The book provides an overview of the most common diabetes-related complications, supporting the clinician in the management of type 2 diabetes in the elderly: from the diagnosis of each complication, to the role of the pharmacological and non-pharmacological interventions.

Depression and Type 2 Diabetes

Depression and Type 2 Diabetes Book
Author : Khalida Ismail,Andreas Barthel,Stefan R. Bornstein,Julio Licinio
Publisher : Oxford University Press
Release : 2018-08-23
ISBN : 0192506293
Language : En, Es, Fr & De

GET BOOK

Book Description :

Type 2 diabetes is a major global health concern, and is predicted to affect between 10% to 25% of the world's population in the next 20 years. This epidemic is mostly attributed to ageing populations and unhealthy lifestyles. Thusly, understanding how the mind interacts with the body is essential in unlocking the psychological, biological, and sociocultural processes that increase the risk of type 2 diabetes and make it such a difficult condition to treat. Depression is a common co-morbid condition and when both conditions are present, this poses a significant challenge to patients, clinicians, and health care systems globally. Depression and Type 2 Diabetes is a unique resource offering a fresh scientific approach to this frequent co-morbidity. Using the latest research and guidelines, this resource provides readers with a comprehensive overview of the subject at the different stages of human lifespan, from the uterine environment where the metabolic thermostat is first set, to growing old with diabetes. Written and edited by international experts in diabetes and depression, Depression and Type 2 Diabetes reviews, critiques, and advances the latest research on the prevalent and complex relationship between depression and type 2 diabetes.

Clinical Research on Diabetic Complications

Clinical Research on Diabetic Complications Book
Author : Anonim
Publisher : MDPI
Release : 2021-01-14
ISBN : 3039438255
Language : En, Es, Fr & De

GET BOOK

Book Description :

Refrigeration, air conditioning, and heat pumps (RACHP) have an important impact on the final energy uses of many sectors of modern society, such as residential, commercial, industrial, transport, and automotive. Moreover, RACHP also have an important environmental impact due to the working fluids that deplete the stratospheric ozone layer, which are being phased out according to the Montreal Protocol (1989). Last, but not least, high global working potential (GWP), working fluids (directly), and energy consumption (indirectly) are responsible for a non-negligible quota of greenhouse gas (GHG) emissions in the atmosphere, thus impacting climate change.

Reverse Alzheimer s Disease Naturally

Reverse Alzheimer s Disease Naturally Book
Author : Michelle Honda
Publisher : Hatherleigh Press
Release : 2019-04-16
ISBN : 157826779X
Language : En, Es, Fr & De

GET BOOK

Book Description :

Breakthrough and effective natural medicine approaches to manage and treat Alzheimer's disease. More than 44 million people are affected by Alzheimer's disease worldwide. Millions of people of all ages are battling this disabling brain impairment, causing a health care crisis of epidemic proportions. Reverse Alzheimer's Disease Naturally provides a comprehensive overview of Alzheimer's disease and how to effectively and naturally manage it. It's a complete resource of healing remedies, dietary recommendations, mental exercises, and protocols. Reverse Alzheimer's Disease Naturally offers practical tips and alternative solutions to popular treatments as well as beneficial supplements and home remedies.